The Long Run with Luke Timmerman

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

Feb 9, 2024
Guest
Robert Ang
Robert Ang, CEO of Vor Bio, discusses using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia. Topics include personal background, challenges of personalized medicine in cancer treatment, potential applications of CRISPR technology, and financial challenges in biotechnology.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Robert Aang's Background and Upbringing
03:27 • 14min
3
Finding Purpose and the Intersection of Medicine and Business
17:00 • 3min
4
Introduction to the Industry and Role in Cadence Pharmaceuticals
20:10 • 11min
5
Exploring the Challenges and Potential of Personalized Medicine in Cancer Treatment
30:40 • 3min
6
The Role of the Chief Business Officer
33:20 • 8min
7
CRISPR's Potential in Medicine
41:44 • 14min
8
Manufacturing Setup and Financial Challenges
55:43 • 7min